Taking ibuprofen may increase your risk of heart failure
If you're prescribed Tradjenta, be sure to complete the full course unless your doctor specifically tells you to stop
Headaches represent one of the most commonly reported side effects during GLP-1 receptor agonist therapy, occurring in approximately one-quarter of patients during their first month
However, several developments may affect your options: OSA coverage continues for Medicare members meeting criteria (AHI 15, BMI 30, no diabetes) Oral Wegovy launched January 2026 Available via NovoCare at $149-299/month, no injection required Medicare $50/month benefit Expected mid-2026 for qualifying obesity medications (may not include Humana Medicare Advantage) Medicaid expansion Some states adding GLP-1 coverage
For a plain-language background on how semaglutide (Ozempic) works, see the Mayo Clinics overview
59(2): 35866 Tamai I, Ohashi R, Nezu J, et al